image
image
user-login
Patent search/

Bioprocess for Acelerated Mycelium Growth in Submerged Cultures for Edible Fungi

search

Patent Search in India

  • tick

    Extensive patent search conducted by a registered patent agent

  • tick

    Patent search done by experts in under 48hrs

₹999

₹399

Talk to expert

Bioprocess for Acelerated Mycelium Growth in Submerged Cultures for Edible Fungi

ORDINARY APPLICATION

Published

date

Filed on 28 October 2024

Abstract

The cultivation of edible fungi has become an area of growing interest due to the fungi’s high nutritional value, promising therapeutic effects, and potential environmental benefits. Edible fungi, including mushrooms, have been increasingly recognized as sustainable protein sources with various applications in food and health industries. The primary challenge in commercializing fungal products lies in enhancing mycelial biomass production in an efficient and scalable manner. Traditional methods often require extended cultivation times and can be inconsistent in yield. This study focuses on accelerating mycelium growth through the development of an optimized bioprocess for submerged cultures, providing a controlled and reproducible environment that enables faster and more consistent mycelial growth. The bioprocess utilizes submerged fermentation techniques to maintain a stable environment, allowing for precise adjustments to key growth parameters, including pH, temperature, agitation speed, and nutrient composition. Each parameter was systematically varied to determine the conditions that best support mycelial proliferation. Additionally, oxygen transfer rates were given particular attention, as mycelial cells are highly sensitive to oxygen availability. Adequate dissolved oxygen levels are critical for maintaining cellular metabolism and facilitating optimal biomass accumulation in fungi, particularly in large-scale bioreactors. Experimental analysis was conducted on specific strains of edible fungi, examining growth under optimized conditions in submerged culture versus traditional growth methods. The results revealed a significant increase in biomass yield and a notable reduction in cultivation time, demonstrating the submerged bioprocess’s ability to enhance both the efficiency and scalability of fungal cultivation. This study underscores the submerged culture technique as a promising alternative to traditional methods, facilitating a faster, reproducible, and sustainable production model that aligns with the growing demand for edible fungi. The optimized bioprocess developed here offers substantial potential for commercial applications, paving the way for more sustainable production practices in the burgeoning fungal industry.

Patent Information

Application ID202441082440
Invention FieldBIO-MEDICAL ENGINEERING
Date of Application28/10/2024
Publication Number44/2024

Inventors

NameAddressCountryNationality
Dr. Satish KAssociate Professor, Department of Chemistry, Acharya Institute of Technology.BengaluruIndiaIndia
Dr, Girish HProfessor, Dept. of ECE, Cambridge Institute of Technology R K R Puram R Nagar Bengaluru Karnataka 560036IndiaIndia

Applicants

NameAddressCountryNationality
Girish H147, Sri Gangadhareshwara Nilaya, 3rd Cross, Nagasandra Post, Nelagadaranahalli, Bengaluru-560073IndiaIndia
Dr. Satish KAssociate Professor, Department of Chemistry, Acharya Institute of Technology.BengaluruIndiaIndia

Specification

Description:PREAMBLE TO THE DESCRIPTION:
The present invention relates to the field of a bioprocess for accelerated mycelium growth in submerged cultures for edible fungi. In recent years, edible fungi have emerged as a vital component in sustainable food systems due to their nutritional density, therapeutic potential, and low environmental footprint. As global demand for protein-rich, eco-friendly food sources continues to rise, the need for efficient and scalable production of fungi has become increasingly urgent.
Background:
Traditional cultivation methods, while effective, often face limitations in yield consistency, growth speed, and resource utilization, challenging the scalability of fungal production for widespread commercial use.
Summary of the Invention:
The disclosed invention presents a novel system and method for a Bioprocess for Accelerated Mycelium Growth in Submerged Cultures for Edible Fungi. To address these challenges, research has focused on optimizing bioprocesses to accelerate mycelium growth in submerged cultures, which provide a controlled and highly adaptable environment for fungal cultivation. Submerged cultures enable precise manipulation of growth parameters-such as pH, temperature, nutrient composition, and oxygen transfer rates-enhancing mycelial biomass yield and reducing cultivation time compared to conventional methods. This approach not only ensures high productivity but also supports sustainable production practices by utilizing fewer resources.
Description of the Invention:
The development of an optimized submerged bioprocess for edible fungi promises significant advancements in the commercial viability of fungal products, aligning with global sustainability goals and contributing to the growth of alternative protein markets. By harnessing the potential of submerged culture bioprocessing, this study aims to pave the way for accelerated, scalable, and environmentally conscious production of edible fungi, meeting both current and future demands for nutritious, sustainable food sources.
• Nutritional and Environmental Value:
Edible fungi, including various mushrooms, are recognized for their rich nutrient profiles, often containing high levels of protein, fiber, essential amino acids, vitamins, and minerals. They also have low-calorie content and are cholesterol-free, making them an ideal food source in health-conscious diets. Beyond nutrition, some fungi are believed to have therapeutic benefits due to bioactive compounds like polysaccharides and beta-glucans, which may support immune health and have potential anti-cancer and anti-inflammatory properties. Fungi are also sustainable: they can be grown on organic waste, require minimal water and land compared to traditional livestock, and have a low environmental footprint, making them a promising alternative protein source for a sustainable future.
• Commercialization Challenge:
While edible fungi are beneficial, large-scale cultivation faces limitations in terms of efficiency, consistency, and cost. Traditional cultivation methods, like solid-state fermentation on natural substrates, often require extensive time and labor and can lead to variable yields. These challenges create bottlenecks in the supply chain and increase production costs, which ultimately affects pricing and availability in the market. Achieving a scalable, efficient method for mycelium biomass production is thus essential for meeting demand and making fungal products commercially viable.
• Submerged Culture Optimization:
Submerged culture or submerged fermentation refers to cultivating fungi in a liquid nutrient medium, allowing for fine control over the growth environment. This technique allows researchers and producers to systematically adjust critical growth factors such as pH, temperature, agitation (which affects oxygen distribution), and nutrient concentrations to maximize mycelial growth. These optimized conditions create a more consistent and faster growth environment than traditional methods, supporting high productivity and enabling scalability. This bioprocess approach is particularly advantageous for fungal strains that thrive in liquid cultures and respond well to controlled environments.
• Importance of Oxygen Transfer Rates:
Oxygen is essential for fungal cell respiration, which powers cellular metabolism and
growth. In a submerged culture, oxygen must dissolve in the liquid medium to be accessible to mycelial cells. Without sufficient oxygen transfer, mycelial cells may experience stress or slow growth, resulting in lower biomass yields. Large-scale bioreactors present specific challenges for oxygen distribution due to their volume, requiring precise control of aeration and agitation to ensure adequate oxygen reaches all cells. Therefore, optimizing dissolved oxygen levels and transfer rates in bioreactors is crucial for maximizing the biomass and quality of fungal cultures.
• Enhanced Growth and Yield:
Experimental results showed that fungi grown under optimized submerged conditions produced higher yields of mycelial biomass in a shorter period than those cultivated through traditional methods. By carefully adjusting the bioprocess parameters, researchers achieved a faster rate of mycelial proliferation. This increase in biomass and decrease in cultivation time demonstrates that submerged culture bioprocessing can provide substantial production improvements, making it a feasible method for commercial fungal biomass production.
• Commercial Viability:
The optimized submerged bioprocess offers practical benefits for industrial-scale fungal cultivation, including higher productivity and shorter growth cycles. The controlled environment allows for reproducible results, reducing variability between batches, which is critical for commercial applications where consistency is necessary. Faster, more predictable growth cycles mean that production can better meet market demand, and the potential for automation in submerged culture further increases scalability and reduces labor costs, making it an attractive option for large-scale commercial operations.
• Environmental Sustainability:
This bioprocessing method supports sustainability goals by improving efficiency, reducing resource use, and enabling fungal production on a large scale. Fungal cultivation typically has a smaller environmental impact than animal agriculture, and using submerged bioprocessing for fungi reduces land and water use compared to traditional methods. This approach aligns well with global efforts to produce food sustainably, addressing the increasing demand for alternative protein sources. The lower environmental footprint of fungi makes it a particularly appealing choice for addressing food security and sustainability concerns in an ecologically responsible manner.
Medicinal mushrooms, primarily from the higher Basidiomycetes class, represent a
remarkable yet underutilized source of bioactive compounds with wide-ranging potential health benefits. These mushrooms contain various cellular components and secondary metabolites, including polysaccharides, proteins and protein complexes, phenolic compounds, polyketides, triterpenoids, steroids, alkaloids, and nucleotides. These compounds are often extracted from different parts of the mushroom-such as the fruiting body, the mycelium (the vegetative part of the fungus), and the culture broth-each of which offers a unique profile of bioactive substances. The biological activities associated with these compounds span a broad spectrum, including cholesterol-lowering, anti-diabetic, antioxidant, antitumor, immunomodulatory, antimicrobial, and antiviral effects, making them attractive candidates for both industrial application and commercialization.
In recent years, submerged cultivation has gained recognition as a reproducible and efficient approach to cultivate medicinal mushrooms, particularly for producing mycelium and secondary metabolites. Submerged cultivation offers an alternative to traditional solid-state or surface-level cultivation, allowing mushrooms to grow in a liquid nutrient medium, which facilitates easier harvesting and provides a controlled environment for optimizing growth conditions. This method is highly appealing for industrial-scale production because it is amenable to standardization and scale-up, which can lead to more consistent and higher yields. Nevertheless, scaling submerged cultivation for commercial use requires not only methods to boost product yield but also novel production systems that address current technical challenges in this cultivation technique.
Despite significant interest, much remains to be explored regarding the physiological and engineering aspects of submerged cultivation for medicinal mushrooms. Most existing research has centered on producing specific compounds, particularly polysaccharides and ganoderic acids (triterpenoids found in Ganoderma species). These compounds are noted for their health-promoting properties, such as immune modulation and antioxidant activity. However, there is limited research on the full range of potential compounds, including antioxidants and compounds with hemagglutinating (blood-clotting) activity, which submerged cultures could yield.
The objective of this review is to provide a comprehensive overview of the current state and future prospects for submerged cultivation of medicinal mushrooms, emphasizing its potential to generate mycelium and bioactive metabolites on a commercial scale. Additionally, it aims to contribute to the ongoing research and development of new pharmaceutical products derived from mushrooms. By summarizing recent advancements and outlining the metabolic diversity and bioactive potential of submerged mushroom
cultures, this review highlights opportunities for advancing both the scientific understanding and industrial applications of medicinal mushrooms.
Fig 1: Mycelium Growth
Mushrooms have traditionally been valued for their unique flavor and texture, and today they are also recognized as a nutritious food source and a significant reservoir of bioactive metabolites (BAM). Several of these compounds exhibit substantial medicinal and pharmaceutical benefits, offering a range of biological activities with minimal toxicity. These bioactive compounds have been extracted from various mushroom components, including fruiting bodies, mycelia, and culture broths. Recent findings suggest that many Basidiomycetes can efficiently produce mycelial biomass in submerged cultures. However, most research in this area has concentrated on producing polysaccharides and ganoderic acids, while antioxidant and hemagglutinating activities in submerged mushroom cultures remain underexplored. , Claims:I/We Claim:
1. The Edible fungi are highly nutritious, offer potential therapeutic benefits, and serve as sustainable protein sources with applications in food and health industries.
2. A significant challenge in commercial edible fungi production is achieving efficient and scalable mycelial biomass production due to traditional cultivation methods, which are time-intensive and yield inconsistent results.
3. Submerged fermentation cultures offer a controlled, reproducible environment, making it possible to precisely adjust growth parameters-such as pH, temperature, agitation speed, and nutrient composition-to accelerate mycelial growth.
4. Mycelial cells are sensitive to oxygen availability, and optimizing dissolved oxygen levels is critical for maintaining cellular metabolism and maximizing biomass accumulation, especially in large-scale bioreactors.
5. Experimental analysis of specific fungal strains showed that the optimized submerged bioprocess increased biomass yield and reduced cultivation time compared to traditional methods.
6. The submerged bioprocess method provides a faster, more reproducible, and sustainable model for the large-scale production of edible fungi, offering substantial potential for future commercial applications.
7. This optimized bioprocess aligns with global sustainability goals by enabling a scalable and environmentally friendly approach to fungal production, which is increasingly relevant as demand grows in the food and health sectors.

Documents

NameDate
202441082440-COMPLETE SPECIFICATION [28-10-2024(online)].pdf28/10/2024
202441082440-DECLARATION OF INVENTORSHIP (FORM 5) [28-10-2024(online)].pdf28/10/2024
202441082440-DRAWINGS [28-10-2024(online)].pdf28/10/2024
202441082440-FORM 1 [28-10-2024(online)].pdf28/10/2024
202441082440-FORM-9 [28-10-2024(online)].pdf28/10/2024
202441082440-REQUEST FOR EARLY PUBLICATION(FORM-9) [28-10-2024(online)].pdf28/10/2024

footer-service

By continuing past this page, you agree to our Terms of Service,Cookie PolicyPrivacy Policy  and  Refund Policy  © - Uber9 Business Process Services Private Limited. All rights reserved.

Uber9 Business Process Services Private Limited, CIN - U74900TN2014PTC098414, GSTIN - 33AABCU7650C1ZM, Registered Office Address - F-97, Newry Shreya Apartments Anna Nagar East, Chennai, Tamil Nadu 600102, India.

Please note that we are a facilitating platform enabling access to reliable professionals. We are not a law firm and do not provide legal services ourselves. The information on this website is for the purpose of knowledge only and should not be relied upon as legal advice or opinion.